No phaseActive, not recruiting
Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation (PULSAR)
A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
- Sponsor
- Kardium Inc. (Industry)
- Enrolment
- 549 planned
- Conditions
- Paroxysmal Atrial Fibrillation; Persistent Atrial Fibrillation
- Interventions
- Globe Pulsed Field System
- Ages
- adults, older adults
- Registry
- NCT05462145
Full record on ClinicalTrials.gov
From the registry
This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).
Primary outcomes
- Effectiveness endpoint
- Safety endpoint
History
Primary completion expected
Last registry update
Started
Registered